| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/04/1997 | US5599942 Taxoid intermediates |
| 02/04/1997 | US5599928 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy |
| 02/04/1997 | US5599923 Useful for localization, magnetic resonance imaging, radiosensitization, radiation therapy, fluorescence imaging, and photodynamic therapy |
| 02/04/1997 | US5599914 Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/04/1997 | US5599902 Cancer inhibitory peptides |
| 02/04/1997 | US5599833 Sulfonate and carbamate derivatives of 3-aroylbenzo[B]thiophenes |
| 02/04/1997 | US5599820 Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| 02/04/1997 | US5599796 Treatment of urogenital cancer with boron neutron capture therapy |
| 02/04/1997 | US5599789 Method for the treatment of tumours and sarcomas |
| 02/04/1997 | US5599788 Wound healing agents; dermal fibroplast adhesion promoter |
| 02/04/1997 | CA2053820C Method of inhibiting metabolism of cholesterol |
| 02/04/1997 | CA2049496C Sulfonamide derivatives |
| 01/30/1997 | WO1997003203A2 Generation of immune responses to prostate-specific antigen (psa) |
| 01/30/1997 | WO1997003188A2 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 01/30/1997 | WO1997003074A1 4-amino-3-acylnaphthyridine derivatives |
| 01/30/1997 | WO1997003069A1 Heterocyclic compounds and pharmaceutical compositions containing them |
| 01/30/1997 | WO1997003050A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 01/30/1997 | WO1997003047A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors |
| 01/30/1997 | WO1997002832A1 Lyophilized hgf preparations |
| 01/30/1997 | WO1997002817A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | WO1996040745A3 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
| 01/30/1997 | WO1996040739A3 Urethane mediated, gst specific molecular release systems |
| 01/30/1997 | CA2226623A1 Compounds useful in the treatment of neurofibromatosis |
| 01/30/1997 | CA2224414A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 01/30/1997 | CA2224411A1 Novel farnesyl transferase inhibitors, preparation thereof and pharmaceutical compositions containing said inhibitors |
| 01/29/1997 | EP0756008A2 Substrate for detection of mammalian 5-C-DNA methyltransferase |
| 01/29/1997 | EP0755931A1 Dihydropyridine and pyridine derivatives and process for their preparation |
| 01/29/1997 | EP0755919A2 Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them |
| 01/29/1997 | EP0755917A1 N,N'-di(aralkyl) N,N'-di(carboxyalkyl) alkylen- di- or triamino-derivatives and N-(aralkyl) N'-(carboxyalkyl) N,N'-di (carboxyalkyl) alkylen- di- or triamino-derivatives and their use in pharmacy and cosmetics |
| 01/29/1997 | EP0755683A1 Immunotherapy of tumor with monoclonal antibody against the 17-1A antigen |
| 01/29/1997 | EP0755675A1 Dermatological and/or pharmaceutical composition, process of preparation and utilization |
| 01/29/1997 | EP0755454A1 Aav-mediated delivery of dna to cells of the nervous system |
| 01/29/1997 | EP0755445A1 Cell-cycle regulatory proteins, and uses related thereto |
| 01/29/1997 | EP0755443A1 Tissue-specific enhancer active in prostate |
| 01/29/1997 | EP0755399A1 Lobaplatinum trihydrate |
| 01/29/1997 | EP0755383A1 Inhibitors of farnesyl-protein transferase |
| 01/29/1997 | EP0755257A1 Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection |
| 01/29/1997 | EP0675878B1 Novel vitamin d analogues |
| 01/29/1997 | EP0652755B1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine |
| 01/29/1997 | EP0633878B1 Novel vitamin d analogues |
| 01/29/1997 | CN1141637A Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/29/1997 | CN1141633A 4-heterocyclyl-substituted Quinazoline derivatives, method for prepn. of same and the use as anti-cancer agent |
| 01/29/1997 | CN1141632A 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity |
| 01/29/1997 | CN1141627A Novel indol derivatives useful to treat estrogen-related neoplasms and disorders |
| 01/29/1997 | CN1141625A Vitamin D amine and amine derivatives |
| 01/29/1997 | CN1141298A Pyrimidine-fused heterocyclic compound anti-cancer agents |
| 01/29/1997 | CA2182226A1 Dermatological or pharmaceutical composition; process for preparing and uses |
| 01/29/1997 | CA2180505A1 Substrate for detection of mammalian 5-c-dna methyltransferase |
| 01/28/1997 | US5597932 Intermediate for the preparation of 19-nor vitamin D compounds |
| 01/28/1997 | US5597899 Tumor necrosis factor muteins |
| 01/28/1997 | US5597898 NF-κB activation regulatory protein, IκB-β |
| 01/28/1997 | US5597830 Antitumor agents for prostate or breast cancer |
| 01/28/1997 | US5597715 7,42-Bis(O-demethyl)rapamycin |
| 01/28/1997 | US5597710 Genetic engineering |
| 01/28/1997 | US5597709 Human growth hormone splice variants hGHV-2(88) and hGHV-3(53) |
| 01/28/1997 | US5597582 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 01/28/1997 | US5597578 TGF-β protein compositions for inhibition of cell proliferation |
| 01/28/1997 | US5597569 Bryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioica |
| 01/27/1997 | CA2182112A1 N,n'-di(aralkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine and n-(aralkyl) n'-(carboxyalkyl) n,n'-di(carboxyalkyl) alkylene di- or triamine derivatives and their use in pharmaceutical or cosmetic applications |
| 01/23/1997 | WO1997002421A1 Pumping device |
| 01/23/1997 | WO1997002354A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 01/23/1997 | WO1997002351A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | WO1997002342A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 01/23/1997 | WO1997002280A1 Breast specific genes and proteins |
| 01/23/1997 | WO1997002267A1 New pyrido-thiopyranoindazoles with antitumor activity |
| 01/23/1997 | WO1997002266A1 Pyrrolopyrimidines and processes for the preparation thereof |
| 01/23/1997 | WO1997002244A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 01/23/1997 | WO1997002045A1 Therapeutic agents and autoimmune diseases |
| 01/23/1997 | WO1997002034A1 Anti-infection, anti-inflammatory and anti-tumour drug |
| 01/23/1997 | WO1997002029A1 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines |
| 01/23/1997 | WO1997002026A1 Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases |
| 01/23/1997 | WO1996040253A3 Rna photocleavage using texaphyrins |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | CA2226310A1 New pyrido-thiopyranoindazoles with anti-tumor activity |
| 01/23/1997 | CA2226258A1 Recombinant protein having bacteriophage endosialidase enzymatic activity |
| 01/23/1997 | CA2225824A1 Breast specific genes and proteins |
| 01/23/1997 | CA2224940A1 Interaction of p53 with transcription factor dp-1 |
| 01/22/1997 | EP0754693A2 Novel aminophenylphosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754682A1 Aminostilbazole derivative and medicine |
| 01/22/1997 | EP0754302A1 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 01/22/1997 | EP0754242A1 OLIGONUCLEOTIDE N3'$m(7)P5' PHOSPHORAMIDATES: SYNTHESIS AND COMPOUNDS; HYBRIDIZATION AND NUCLEASE RESISTANCE PROPERTIES |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754183A1 Novel spiro[indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as a drug |
| 01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
| 01/22/1997 | EP0754057A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING $g(a)-GALACTOSYL EPITOPES |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0754036A1 Permanently ionic derivatives of steroid hormones and their antagonists |
| 01/22/1997 | EP0754035A1 Carotenoid agent for inhibiting the conversion of epithelial cells to tumours |
| 01/22/1997 | EP0754033A1 Heterofunctional, mucoadhesive dosage form |
| 01/22/1997 | EP0754030A1 Method for stabilizing duocarmycin derivatives |
| 01/22/1997 | EP0669916B1 Novel method for preparing taxane derivatives, novel derivatives thus obtained and compositions containing them |
| 01/22/1997 | EP0593656B1 Novel compositions based on taxane class derivatives |
| 01/22/1997 | EP0593419B1 Inhibitors for glycosaminosyl transferase-v |
| 01/22/1997 | CN1141059A P53-binding polypeptides and polynucleotides encoding same |
| 01/22/1997 | CN1141045A Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene) cytidine |
| 01/22/1997 | CN1141042A Enantiomerically pure (+)-liarozole |
| 01/22/1997 | CN1141041A Enantiomerically pure (-)-liarozole |